The findings show that metabolic syndrome, a cluster of conditions that includes obesity, insulin resistance and reduced physical activity, occurs in female mice when estrogen signaling in specific areas of the brain is shut down.
“It is well documented that mice missing the gene for estrogen receptor a become obese,” says Pfaff, head of the Laboratory of Neurobiology and Behavior. “But because every cell in these ‘knockout’ mice has been missing estrogen signaling from birth, these results are confounded by potential effects on overall brain development. Using a targeted approach, we interfered with the receptor’s synthesis only in the neurons in the ventromedial nucleus of the hypothalamus, and found that these mice also become obese.”
The ventromedial nucleus plays an essential role in the control of energy balance: When intentionally harmed, the mice become obese. Nerve cells in this area of the brain also express estrogen receptor a at very high levels.
Using a novel method of genetic manipulation developed by Sergei Musatov, a former postdoc and first author of the current paper, the scientists tested the role of estrogen receptor alpha in specific areas of the brain. The technique uses a virus to deliver strands of interfering RNA to the neurons that would halt production of the estrogen receptor a protein. The affected mice immediately started to gain weight, even though the amount of food they were initially eating didn’t change.
“We found that the increase in food was secondary, the weight gain occurred first and the mice started to eat more simply to maintain their new body weight,” says Musatov. “Estrogen signaling obviously plays an important role in the ventromedial nucleus to help maintain normal body weight.”
The mice missing estrogen receptor alpha also expended less energy – they were less active than regular mice and had a slower metabolism. They also developed several hallmark features of metabolic syndrome in humans, including glucose intolerance and resistance to insulin.
Citation: Proceedings of the National Academy of Sciences 104(7): 2501-2506 (February 13, 2007)
Source: Rockefeller University
Related stories:
Clue to genetic cause of fatal birth defect
A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine.
6 environmental research studies reveal critical health risks from plastic
Exposure to Bisphenol A (BPA), phthalates and flame retardants (PBDEs) are strongly associated with adverse health effects on humans and laboratory animals. A special section in the October 2008 issue of
Environmental Research, "A Plastic World" provides critical new research on environmental contaminants and adverse reproductive and behavioral effects.
Improved estrogen reception may sharpen fuzzy memory
Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.
Effects of progesterone on Alzheimer's disease
The first study on progesterone and Alzheimer’s disease has found no clear preventive benefit for the widely prescribed hormone in an animal model.
Sensory organ, not brain, differentiates sexual behavior in some mammals
For years, scientists have searched in vain for slivers of the brain that might drive the dramatic differences between male and female behavior. Now biologists at Harvard University say these efforts may have fallen flat because such differences may not arise in the brain at all.
How does day length affect aggression in mice? It's in the genes
Imagine if a naturally occurring chemical in your body could help make you feel more calm and relaxed – but it would only work during the long days of summer. The same chemical would, instead, make you aggressive and nasty when you were exposed to less daylight during the winter.
To recognize their friends, mice use their amygdalas
Even those who can’t remember names can usually recall faces. New research from Rockefeller University suggests that a simple brain chemical, a neuropeptide called oxytocin, is a reason.
Androgen therapy may slow progress of Alzheimer's disease
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. The findings, published in the December 20 issue of
The Journal of Neuroscience, provide new insight into the relationship between testosterone loss and AD, which affects 4.5 million Americans.
